Why the study?
With the expansion of minimally invasive transcatheter treatments for valvular heart disease, preprocedural imaging strategies vary depending on the targeted valve.
This review highlights the critical role of preprocedural CT imaging and postprocessing in planning transcatheter treatments for valvular heart disease.
Multimodality imaging in expanding TAVR use leaves open optimal protocols; dedicated prospective studies needed before practice change.
Minimally invasive strategies to treat valvular heart disease have emerged over the past 2 decades. The use of transcatheter aortic valve replacement in the treatment of severe aortic stenosis, for example, has recently expanded from high- to low-risk patients and became an alternative treatment for those with prohibitive surgical risk. With the increase in transcatheter strategies, multimodality imaging, including echocardiography, CT, fluoroscopy, and cardiac MRI, are used. Strategies for preprocedural imaging strategies vary depending on the targeted valve. Herein, an overview of preprocedural imaging strategies and their postprocessing approaches is provided, with a focus on CT. Transcatheter aortic valve replacement is reviewed, as well as less established minimally invasive treatments of the mitral and tricuspid valves. In addition, device-specific details and the goals of CT imaging are discussed. Future imaging developments, such as peri-procedural fusion imaging, machine learning for image processing, and mixed reality applications, are presented.
No takes yet. Share an insight, caveat, or question.
Rudziński et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: